Recent Company News

• 07:06 AM ET Jul 01, 2025
  

  EDAP TMS announces transition to U.S. domestic filer status from foreign private issuer effective Jan 2026 ($1.65, 0.00)

• 05:45 PM ET May 15, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 12:49 PM ET May 15, 2025
  

  EDAP TMS downgraded to neutral from overweight at Piper Sandler (timing uncertain) ($1.78, -0.38)

• 07:10 AM ET May 15, 2025
  

  EDAP TMS reports Q1 EPS (€0.19) vs FactSet (€0.15) [3 est, (€0.16)-(0.14)] ($2.16, 0.00)

• 07:05 AM ET Apr 29, 2025
  

  EDAP announces results from the FARP randomized controlled trial presented at the AUA annual meeting ($2.18, 0.00)

• 05:44 AM ET Apr 04, 2025
  

  EDAP TMS downgraded to hold from buy at Jefferies (3-April) ($1.91, 0.00)

• 09:16 AM ET Mar 27, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:27 AM ET Mar 27, 2025
  

  StreetAccount Summary - US Pre-market trading

• 07:15 AM ET Mar 27, 2025
  

  EDAP TMS reports Q4 EPS (€0.05) vs FactSet (€0.10) [3 est, (€0.11)-(0.09)] ($2.05, 0.00)

• 07:24 AM ET Jan 13, 2025
  

  EDAP reports preliminary Q4 sales of 11 Focal One Systems ($2.10, 0.00)